Understanding lipodystrophy and the role of Tesamorelin

 

Here you have an exhaustive and detailed analysis, adapted to the medical and regulatory context of Spain, on the relationship between lipodystrophy and Tesamorelina.

 

This is a topic that crosses the border between endocrinology, infectious diseases and aesthetics, and it is essential to understand it well so as not to fall into myths.

 

1. What is Lipodystrophy? (The Base Problem)

 

Lipodystrophy is a syndrome characterized by an abnormal distribution of body fat. It's not simple obesity; It's a mistake in how the body stores and metabolizes the adipose tissue.

 

Even though there are rare genetic forms, in the context of Tesamorelina, we often speak exclusively of HIV-associated Lipodystrophy.

 

1. La Causa: The price of survival

 

With the arrival of highly active antiretroviral treatments (TARGA) at the end of the 1990s in Spain, AIDS mortality fell sharply. However, an unexpected secondary effect emerged: medications (especially protein inhibitors and ancient nucleoside analogues such as stavudine or zidovudine) altered fat metabolism.

 

1. Los Dos Rostros de la Sickness

 

The patient suffers a “double condemnation” aesthetic and metabolic:

 

1. Lipoatrophy (Lost): Fat disappears from the face (hundred muscles), arms, legs and glutes. The veins and muscles are marked.

 Note: Tesamorelina is NOT suitable for this.

 

2. Lipohypertrophy (Accumulation): Fat accumulates massively and pathologically in central areas:

 Abdomen: Deep visceral fat (hard and prominent belly).

 Cervical back: Called “buffalo hump” (accumulation of fat behind the neck).

 Breasts: Gynecomastia in men or breast growth in women.

 

1. El Riesgo en España: More of all the aesthetics

 

In infectious disease consultations in Spanish hospitals (such as La Paz, Clínic or Gregorio Marañón), doctors know that they are not only “bad”. Visceral fat is metabolically active and dangerous: it releases fatty acids and inflammation in the liver, causing:

 

 Insulin resistance and diabetes.

 Dyslipemia (high cholesterol and triglycerides).

 High cardiovascular risk (heart attacks).

 

2. El Papel de la Tesamorelina (The Specific Solution)

 

Here comes Tesamorelina (Egrifta) into play. It is the first and only drug approved by the FDA specifically to treat the accumulation of abdominal visceral fat in patients with HIV.

 

1. Why Tesamorelina and not on a diet?

 

The fat of lipodystrophy is “rebel”. Although there is a metabolic failure caused by drugs or by the virus itself, diet and exercise often fail. A patient can kill himself by doing abdominals and eating meat, and his arms will become thinner, but his visceral belly will be lower.

 

Tesamorelina causes this metabolic blockage.

 

1. Mechanism of Action in Lipodystrophy

 

1. The Defect: Patients with HIV lipodystrophy may have reduced or altered Growth Hormone (GH) secretion.
2. Correction: Tesamorelina (analogue of GHRH) stimulates the pituitary gland so that it recovers GH pulsation.
3. The Diana Effect: As physiological GH rises, it preferentially attacks visceral fat receptors (which are abundant).
4. Result: The deep grease that surrounds the viscera is “burned”, reducing the abdominal perimeter and relieving pressure on the internal organs.

 

3. Reality Clinic: What can be achieved and what can’t be done?

 

The clinical studies (and real-use experience) show a true collection of topics:

 

 LO QUE SÍ HACE:

 Reduce visceral grease between a 15% and a 18%.

 Improves body image and reduces social stigma (the “HIV belly” is a visible marker of the disease).

 It can slightly improve triglyceride levels.

 

 LO QUE NO HACE:

 Do not return fat to your face or legs: It does not cure lipoatrophy. For this reason, in Spain, Social Security usually covers facial relief or reconstructive plastic surgery in serious cases.

 Do not lose weight “all over the body”: It is not a drug for general obesity (subcutaneous fat).

 It is not a permanent cure: If you want to take Tesamorelina, the visceral fat will accumulate again within months (rebound effect).

 

4. Regulatory Situation and Availability in Spain

 

This is the most critical point for a Spanish patient.

 

1. FDA vs. EMA Approval:

 In the United States, the FDA approved Egrifta years ago.

 In Europe (EMA), the situation has been more complex. Even though it was evaluated, it is not a drug that you can find in the pharmacy on the corner with a green prescription. Commercialization in Europe has involved a lot of work, mainly because the authorities considered that long-term metabolic benefits would not always compensate for risks or high costs.

 

2. How do you get there in Spain?

 Legal Way (Very Restricted): Only through a Hospital Pharmacy as “Extra National Medicine” or “Compassionate Use”.

 You HIV specialist (infectious disease specialist) must justify to the hospital management and the AEMPS that your case is serious, that you have high cardiovascular risk due to visceral fat and that you have not responded to anything more. It's a difficult bureaucratic procedure.

 

 Via Mercado Gris/Negro: Many bodybuilding or lipodystrophy patients who cannot access hospital resort to purchasing the peptide online. This addresses the previously mentioned quality and legal risks.

 

5. Specific Secondary Effects in HIV Patients

 

The use of Tesamorelina in this group of patients requires extreme vigilance on the part of the endocrine system:

 

 Diabetes: Patients with lipodystrophy have a predisposition to diabetes. The Tesamorelina rises in sugar. It is a dangerous combination that requires monitoring Glycosylated Hemoglobin (HbA1c) constantly.

 Interactions: It is important to ensure that it does not interfere with the antiretroviral “coctel”, although it is generally safe in this regard.

 Tumor Risk: Given that patients with HIV have an immune system with a history of compromise and a slightly increased risk of certain cancers, raising IGF-1 (a cell growth factor) is always done with caution.

 

 Summary

 

Lipodystrophy is a devastating physical and psychological sequel to HIV treatment. Tesamorelina represents the only pharmacological tool capable of effectively reversing the accumulation of visceral fat.

 

However, in Spain, it is not a standard first-line treatment. The usual approach to Public Health is:

 

1. Change of antiretroviral medication (to more modern drugs with less lipodystrophic profile).
2. Dieta y ejercicio estricto.
3. Reconstructive surgery (liposucción) covered by Social Security in severe cases.
4. Tesamorelina (only in exceptional cases and under strict hospital control).

 

SERMORELIN PEPTIDE.

Recommended for improving your health, your well-being and your recovery.

How it works:

Stimulates the pituitary gland to release natural GH, activating the body's physiological production.

For whom is it indicated:

Peopleas con sueño lighto.

Patients with fatigue and low energy.

Men and women older than 30 years.

People looking for gentle anti-aging.

People who want to improve their skin and collagen.

What a improvement:

Deep dream.

Muscle recovery.

Slight increase in muscle mass.

Firmness of the skin.

Energy and vitality.

Sermorelin → smooth and sueño natural GH.

Safe and effective under the supervision of a specialist doctor.

Approved by the FDA.

 

Tesamorelin peptide.

Powerful for visceral fat and metabolism.

How it works:

Stimulates GH and IGF-1 with greater intensity, improving body composition and reducing persistent abdominal fat.

For whom is it indicated:

Persons with persistent abdominal fat.

Slow metabolism.

From the age of 30-35.

Those looking for performance and aesthetics.

They may find it difficult to gain muscle mass.

What a improvement:

Reduction of visceral fat.

Increase in lean mass.

Deep dream.

Muscle recovery.

Energy and vitality.

Fast metabolism.

Tesamorelin: Visceral fat and metabolism.

Safe and effective under the supervision of a qualified doctor.

Approved by the FDA.

 

Elamipretide SS-31 peptide.

Mitochondrial peptide: energy, concentration and longevity.

How it works:

It acts directly on the mitochondria, restoring energy efficiency and reducing cellular inflammation.

For whom is it indicated:

Constant fatigue.

Low vitality.

Seniors over 35 years old.

Overworked professionals and sportspeople.

Quienes buscan longevidad.

What a improvement:

ATP energy.

Concentration and mental clarity.

Muscle recovery.

Cellular protection.

Mood and well-being.

Longevity.

SS-31 Mitochondrial energy and deep anti-aging.

Safe and effective if used under the supervision of a qualified doctor.

Approved by the FDA.

 

Doctor G Medical Excellence: Health, Bienestar and Longevidad

4243 W Hillsboro blvd Coconut Creek, 33073, FL

Phone: +1 (954) 638-1515

Understanding lipodystrophy and the role of Tesamorelin